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Summary 
 
Previous research has shown that the 7-11 
Cosynch protocol using melengestrol acetate 
(MGA) is effective in synchronizing beef 
heifers.  This study compared MGA and a 
vaginal insert containing progesterone (CIDR) 
in the 7-11 Cosynch protocol on beef heifers.  
Replacement beef heifers (n=179) from three 
herds were assigned to MGA or CIDR treat-
ments.  Beginning on day 1, heifers on the 
MGA treatment were fed to consume 0.5 mg 
daily of MGA for 7 days.  On day 7, the last 
day of MGA feeding, the MGA heifers re-
ceived an injection of Lutalyse1 (PGF2α).  
Heifers on the CIDR treatment received a 
CIDR on day 3; on day 9 the CIDR was re-
moved, and heifers received an injection of 
Lutalyse.  On day 11, all heifers received an 
injection of OvaCyst2 (gonadotrophin-
releasing hormone; GnRH), followed by an-
other injection of Lutalyse® 7 days later (day 
18).  At 48 hours after the final Lutalyse injec-
tion, all heifers were time inseminated and 
received an injection of OvaCyst.  Pregnancy 
status was determined 33 days after breeding 
by ultrasonography.  No difference in preg-
nancy rate was observed between the CIDR 
(46%) and MGA (47%) treatments. 
 
Introduction 
 
Artificial insemination offers several ad-
vantages, including improving genetics, short-
ening the calving season, and creating a more 
uniform calf crop, yet many beef producers 
have yet to embrace this technology.  One 
possible explanation is that conception rates 
are not yet acceptable, given the time and cost 
involved.  Time could be reduced by shorten-
ing the synchronization time and by more ef-
fectively synchronizing the estrous cycle and 
time of ovulation to yield greater conception 
rates to a timed artificial insemination. 
 
Use of a progestin in synchronization pro-
tocols is desirable because it synchronizes the 
estrous cycle by extending the luteal phase 
and also induces cyclicity in anestrus or pre-
pubertal females.  The progestins most com-
monly used by beef producers are 
melengestrol acetate (MGA), given orally, and 
the Eazi-Breed CIDR1, a vaginal insert con-
taining progesterone. Gonadotrophin-releasing 
hormone (GnRH) is also regularly included in 
estrous synchronization to control timing of 
follicular waves and ovulation. 
 
The most commonly used synchronization 
protocol for beef heifers consists of feeding 
MGA for 14 days, followed by heat detection 
and breeding 17 to 19 days later.  More re-
cently, protocols have been tested that shorten 
the time of progestin administration (7 vs. 14 
days) and overall time to breeding (11 vs. 33 
days).  One example is the 7-11 Cosynch, 
which is composed of 7 days of MGA feeding, 
 
 
         
 
 1Lutalyse and Eazi-Breed CIDR are registered trademarks of Pharmacia Animal Health. 
 2OvaCyst is a registered trademark of Phoenix Scientific. 
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followed by the Cosynch protocol starting on 
day 11 (Figure 1). 
 
We previously have reported acceptable 
conception rates from using MGA with the 7-
11 Cosynch protocol.  Here, we compare 
MGA and the CIDR as progestin sources in 
the 7-11 Cosynch protocol.   
 
Experimental Procedures 
 
Three groups of yearling heifers (n=179) from 
the Kansas State University Purebred Unit and 
the Cow-Calf Unit were used in this study.  
Heifers were blocked by weight (and breed for 
the purebred heifers) and assigned to one of 
two treatments: MGA or CIDR.  Heifers in the 
MGA treatment (Figure 1) were group-fed 0.5 
mg/heifer daily of MGA (Pharmacia Animal 
Health, Kalamazoo, MI) in a grain sorghum 
carrier, beginning on day 1.  On the last day of 
MGA feeding (day 7), heifers were injected 
with Lutalyse (5 mL intramuscular).  Heifers 
in the CIDR treatment (Figure 1) received an 
 
Eazi-Breed CIDR on day 3.  On day 9, the 
CIDR was removed and heifers received an 
injection of Lutalyse.  On day 11, heifers from 
both treatment groups received 2 mL (intra-
muscular) of OvaCyst.  On day 18, all heifers 
received an injection of Lutalyse.  Timed in-
semination followed 48 hours later, at which 
time heifers were injected with OvaCyst. 
Pregnancy status was determined by ultra-
sonography 33 days after insemination. 
 
Results and Discussion 
 
Overall, 84 of 179 (47%) heifers were 
pregnant.  There were no treatment differences 
between MGA and CIDR in pregnancy rate; 
42 of 89 (47%) for MGA and 42 of 90 (46%) 
for CIDR.  These pregnancy rates were as 
much as 15 to 20% lower than in previous tri-
als using the 7-11 Cosynch timed artificial in-
semination treatment with MGA.  In this di-
rect comparison of MGA and CIDR, however, 
there was no advantage of using a CIDR in 
place of MGA. 
 
 
 
 
Figure 1.  The 7-11 Cosynch protocols using either melengestrol acetate (MGA) or a  
vaginal insert containing progesterone CIDR as the progestin source.  Prostaglandin F2α 
(PGF2α) was provided as Lutalyse (5 mL, intramuscular).  OvaCyst (2 mL, intramuscular) served 
as the source of gonadotrophin-releasing hormone (GnRH). 
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